Skip to content
Recall Observatory FDA recall evidence

Drug product

Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01

D-0398-2026

February 04, 2026

Class II

Product summary

Firm
SOMERSET THERAPEUTICS LLC
Event
Event 98388
Status
Ongoing
Classification
Class II
Quantity
62190 vials
Official record key
drug-enforcement:D-0398-2026

Official wording

Reason: Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.

Code information: Lot #: A240421, Exp 07/31/2026

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications